Bromocriptine Mesylate

Spécifications

22260-51-1Numéro CAS

244-881-1Numéro CE

(6aR,9R)-5-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;methanesulfonic acidNom IUPAC

C33H44BrN5O8SFormule chimique

750.7 g/molMasse molaire

BROMOCRIPTINE MESYLATE; 22260-51-1; Bromocriptine mesilate; Pravidel; Cycloset; Bagren; Bromocriptine methanesulfonate; CB-154 mesylate; Cb-154 mesilate; 2-Bromoergocryptine Mesylate; 2-Bromo-alpha-ergocryptine mesylate; DTXSID6020197; FFP983J3OD; NSC-755915; DTXCID00197; CHEBI:3182; Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, monomethanesulfonate (salt), (5'alpha)-; Mesylate, Bromocriptine; RefChem:56424; 2 Bromoergocryptine Mesylate; Mesylate, 2-Bromoergocryptine; 2 Bromoergocryptine Methanesulfonate; 2-Bromoergocryptine Methanesulfonate; Methanesulfonate, 2-Bromoergocryptine; (5'S)-2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione monomethanesulfonate; 244-881-1; Parlodel; Bromocryptine mesylate; Bromergon; (+)-Bromocriptine methanesulfonate; CB 154; 2-Bromoergocryptine monomethanesulfonate (salt); Bromocriptine (mesylate); 2-Bromo a-Ergocryptine Mesylate; CB-154; C33H44BrN5O8S; MFCD00069218; Bromocryptine methanesulfonate; (5'a)-2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione mesylate; Bromocriptine mesylate [USAN]; NSC169774; SR-01000597796; EINECS 244-881-1; UNII-FFP983J3OD; 2-Bromo-alpha-ergocryptine methanesulfonate; SR-01000075356; MFCD09028065; 2-Bromine-alpha-ergocryptine methanesulfonate; 2-Bromo-alpha-ergokryptine-mesilate [German]; Bagre n; 2-bromoergocriptine; Bromocriptine mesylate [USAN:USP]; Parlodel (TN); 2-Bromo-alpha-ergokryptine-mesilate; Prestwick_771; CAS-22260-51-1; Bromocriptine mesilate CRS; alpha-Ergocryptine, 2-bromo-, methanesulfonate; SCHEMBL40559; 2-Bromo-12'-hydroxy-5'alpha-isobutyl-2'-isopropylergotaman-3',6',18-trione monomethanesulphonate; Bromocriptine mesylate (USP); Bromocriptine mesilate (JP18); orb1225623; CHEMBL1200503; SCHEMBL29360283; 2-Bromo ?-Ergocryptine Mesylate; CB 154 methanesulfonate (salt); HMS1568I04; HMS3260D03; HMS3411K09; HMS3675K09; HMS3712I04; MSK11358; BROMOCRIPTINE MESILATE [JAN]; Tox21_303597; Tox21_500171; HB1813; HY-12705A; BROMOCRIPTINE MESYLATE [VANDF]; .alpha.-Ergocryptine, methanesulfonate; AKOS015896276; BROMOCRIPTINE MESILATE [MART.]; BROMOCRIPTINE MESILATE [WHO-DD]; BROMOCRIPTINE MESYLATE [USP-RS]; CCG-220121; CCG-221475; CS-6048; EBC-102075; FB19032; LP00171; NSC 755915; NSC-169774; NCGC00257268-01; NCGC00260856-01; BB164266; Bromocriptine mesylate - Bio-X trade mark; BROMOCRIPTINE METHANESULFONATE [MI]; BROMOCRIPTINE MESYLATE [ORANGE BOOK]; 2-Bromo-a-ergocryptine methanesulfonate salt; BROMOCRIPTINE MESILATE [EP MONOGRAPH]; EU-0100171; NS00084669; BROMOCRIPTINE MESYLATE [USP MONOGRAPH]; B 2134; D00780; D81822; 2-Bromo-.alpha.-ergocryptine monomethanesulfonate; Bromocriptine mesilate for system suitability CRS; SR-01000075356-1; SR-01000597796-1; SR-01000597796-2; Q27105974; 2-BROMOERGOCRYPTINE MONOMETHANESULPHONATE (SALT); (5'?)-2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione methanesulfonate; (5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-2'-(propan-2-yl)-3',6',18-trioxoergotaman methanesulfonate; (5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-3',6',18-trioxo-2'-(propan-2-yl)ergotaman methanesulfonate (salt); (5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman methanesulfonate; (6aR,9R)-5-Bromo-N-((2R,5S,10aS,10bS)-10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxooctahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide methanesulfonate; (6aR,9R)-5-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;methanesulfonic acid; (6aR,9R)-5-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-isobutyl-4-isopropyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;methanesulfonic acid; Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5.alpha.)-, methanesulfonate (1:1); Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5alpha)-, methanesulfonate (1:1); ERGOTAMAN-3',6',18-TRIONE, 2-BROMO-12'-HYDROXY-2'-(1-METHYLETHYL)-5'-(2-METHYLPROPYL)-, MONOMETHANESULFONATE (SALT), (5'.ALPHA.)-; ERGOTAMAN-3',6',18-TRIONE, 2-BROMO-12'-HYDROXY-2'-(1-METHYLETHYL)-5'-(2-METHYLPROPYL)-, MONOMETHANESULPHONATE (SALT), (5'.ALPHA.)-; Methanesulfonic acid--2-bromo-12'-hydroxy-5'alpha-(2-methylpropyl)-3',6',18-trioxo-2'-(propan-2-yl)ergotaman (1/1)Synonymes